Tel Aviv University 
Welcome,         Profile    Billing    Logout  
 1 Product   0 Diseases   1 Product   1 Trial   8471 News 


12345678910111213...6869»
  • ||||||||||  NurOwn (MSC-NTF) / BrainStorm Cell Therap
    Let us try NurOwn!! (Twitter) -  Jul 27, 2023   
  • ||||||||||  MSC-NTF / BrainStorm Cell Therap
    Weneeeed NurOwn! (Twitter) -  May 12, 2023   
  • ||||||||||  MSC-NTF / BrainStorm Cell Therap
    Small Extracellular Vesicles From MSC-NTF Cells Induce Significant Improvement in Inflammatory Lung Disease Models (Walter E. Washington Convention Center, Room 143 A-C (Street Level)) -  Mar 25, 2023 - Abstract #ATS2023ATS_3779;    
    A pre-specified analysis of participants with baseline ALSFRS-R 35 (n = 58) showed a clinical response rate at 28 wk of 35% MSC-NTF and 16% placebo (OR = 2.6, p = 0.29). We observed significant treatment effects of MSC-NTF-derived sEV, suggesting that MSC-NTF derived sEV may offer a promising treatment option for acute pulmonary pathologies associated with inflammation and fibrosis.
  • ||||||||||  NurOwn (MSC-NTF) / BrainStorm Cell Therap
    nurown next (Twitter) -  Mar 22, 2023   
  • ||||||||||  Comirnaty (tozinameran) / Pfizer, Fosun Pharma, BioNTech, Coronavirus Vaccine / Tel Aviv University, NeoPharm
    Review, Journal:  Susac syndrome following COVID-19 vaccination: a case-based review. (Pubmed Central) -  Mar 7, 2023   
    It has been previously described following vaccination and, most recently, few cases following coronavirus vaccines. We here describe a case of a previously healthy 49-year-old man diagnosed with SaS 5 days following the first dose of the BNT162b2 COVID-19 vaccine.
  • ||||||||||  NurOwn (MSC-NTF) / BrainStorm Cell Therap
    #NurOwn (Twitter) -  Feb 9, 2023   
  • ||||||||||  NurOwn (MSC-NTF) / BrainStorm Cell Therap
    #NurOwn (Twitter) -  Feb 9, 2023